Among women with GPV in genes that were moderate-risk for BC and high-risk for OC (group MH—RAD51C, RAD51D), PRS was the most cost-effective among those with BC, OC or BC+OC family history, although in the BC and BC+OC family history groups, CRA generated the highest QALYs. The gene discussed is RAD51D; the disease is breast cancer.